Financhill
Buy
59

PDEX Quote, Financials, Valuation and Earnings

Last price:
$41.95
Seasonality move :
10.52%
Day range:
$39.71 - $41.65
52-week range:
$23.47 - $70.26
Dividend yield:
0%
P/E ratio:
11.95x
P/S ratio:
1.90x
P/B ratio:
3.15x
Volume:
41.3K
Avg. volume:
30.5K
1-year change:
-23%
Market cap:
$130.6M
Revenue:
$66.6M
EPS (TTM):
$3.35
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue $38M $42M $46.1M $53.8M $66.6M
Revenue Growth (YoY) 9.17% 10.55% 9.62% 16.83% 23.68%
 
Cost of Revenues $24.5M $28.7M $33.3M $39.3M $47.1M
Gross Profit $13.6M $13.4M $12.8M $14.6M $19.5M
Gross Profit Margin 35.7% 31.79% 27.78% 27.02% 29.3%
 
R&D Expenses $4.4M $3M $2.8M $3.2M $3.6M
Selling, General & Admin $4.7M $5M $4.2M $4.2M $5.2M
Other Inc / (Exp) $3.3M $924K $3.9M -$4.1M --
Operating Expenses $9.1M $8.2M $7M $7.4M $8.8M
Operating Income $4.5M $5.2M $5.8M $7.2M $10.7M
 
Net Interest Expenses $352K $464K $533K $558K $829K
EBT. Incl. Unusual Items $7M $5.7M $9.4M $2.6M $12.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2M $1.1M $2.4M $507K $3.1M
Net Income to Company $5.8M $4.6M $7.1M $2.1M $9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.8M $4.6M $7.1M $2.1M $9M
 
Basic EPS (Cont. Ops) $1.53 $1.26 $1.98 $0.61 $2.73
Diluted EPS (Cont. Ops) $1.48 $1.21 $1.95 $0.60 $2.67
Weighted Average Basic Share $3.8M $3.6M $3.6M $3.5M $3.3M
Weighted Average Diluted Share $3.9M $3.8M $3.6M $3.6M $3.4M
 
EBITDA $5.3M $5.9M $6.6M $8.3M $11.9M
EBIT $4.5M $5.2M $5.8M $7.2M $10.7M
 
Revenue (Reported) $38M $42M $46.1M $53.8M $66.6M
Operating Income (Reported) $4.5M $5.2M $5.8M $7.2M $10.7M
Operating Income (Adjusted) $4.5M $5.2M $5.8M $7.2M $10.7M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $10M $11.1M $11.9M $14.9M $18.5M
Revenue Growth (YoY) 16.28% 11% 7.68% 24.75% 24.43%
 
Cost of Revenues $6.6M $8.1M $8.1M $9.7M $12.8M
Gross Profit $3.4M $3M $3.8M $5.2M $5.7M
Gross Profit Margin 34.32% 26.66% 32.23% 34.58% 31.01%
 
R&D Expenses $980K $929K $805K $843K $768K
Selling, General & Admin $1.1M $1.1M $1M $1.3M $1.5M
Other Inc / (Exp) $149K $431K -$2.6M $433K --
Operating Expenses $2.1M $2M $2M $2.1M $2.6M
Operating Income $1.3M $950K $1.8M $3M $3.1M
 
Net Interest Expenses $120K $130K $133K $152K $200K
EBT. Incl. Unusual Items $1.4M $1.5M -$829K $3.3M $6.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $307K $266K -$214K $853K $1.5M
Net Income to Company $1.1M $1.2M -$615K $2.5M $4.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.1M $1.2M -$615K $2.5M $4.7M
 
Basic EPS (Cont. Ops) $0.29 $0.33 -$0.17 $0.76 $1.43
Diluted EPS (Cont. Ops) $0.28 $0.33 -$0.17 $0.75 $1.40
Weighted Average Basic Share $3.7M $3.6M $3.5M $3.3M $3.3M
Weighted Average Diluted Share $3.8M $3.7M $3.5M $3.3M $3.3M
 
EBITDA $1.5M $1.1M $2.1M $3.3M $3.4M
EBIT $1.3M $950K $1.8M $3M $3.1M
 
Revenue (Reported) $10M $11.1M $11.9M $14.9M $18.5M
Operating Income (Reported) $1.3M $950K $1.8M $3M $3.1M
Operating Income (Adjusted) $1.3M $950K $1.8M $3M $3.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $39.4M $43.1M $46.9M $56.8M $70.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $25.7M $30.4M $33.3M $40.5M $49.8M
Gross Profit $13.7M $12.7M $13.6M $16.3M $20.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $4.3M $2.9M $2.7M $3.2M $3.6M
Selling, General & Admin $5M $4.9M $4.1M $4.5M $5.4M
Other Inc / (Exp) $3.6M $1.2M $920K -$1.1M --
Operating Expenses $9.4M $7.9M $7M $7.9M $9.6M
Operating Income $4.3M $4.8M $6.6M $8.4M $10.8M
 
Net Interest Expenses $418K $474K $536K $578K $877K
EBT. Incl. Unusual Items $5.5M $5.8M $10.3M $6.8M $15M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2M $1.1M $2.7M $1.6M $3.8M
Net Income to Company $5.7M $4.7M $5.3M $5.2M $11.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.3M $4.7M $7.6M $5.2M $11.2M
 
Basic EPS (Cont. Ops) $1.16 $1.30 $2.13 $1.55 $3.43
Diluted EPS (Cont. Ops) $1.12 $1.26 $2.08 $1.53 $3.35
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $5.1M $5.5M $7.6M $9.5M $12M
EBIT $4.3M $4.8M $6.6M $8.4M $10.8M
 
Revenue (Reported) $39.4M $43.1M $46.9M $56.8M $70.2M
Operating Income (Reported) $4.3M $4.8M $6.6M $8.4M $10.8M
Operating Income (Adjusted) $4.3M $4.8M $6.6M $8.4M $10.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $10M $11.1M $11.9M $14.9M $18.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.6M $8.1M $8.1M $9.7M $12.8M
Gross Profit $3.4M $3M $3.8M $5.2M $5.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $980K $929K $805K $843K $768K
Selling, General & Admin $1.1M $1.1M $1M $1.3M $1.5M
Other Inc / (Exp) $149K $431K -$2.6M $433K --
Operating Expenses $2.1M $2M $2M $2.1M $2.6M
Operating Income $1.3M $950K $1.8M $3M $3.1M
 
Net Interest Expenses $120K $130K $133K $152K $200K
EBT. Incl. Unusual Items $1.4M $1.5M -$829K $3.3M $6.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $307K $266K -$214K $853K $1.5M
Net Income to Company $1.1M $1.2M -$615K $2.5M $4.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.1M $1.2M -$615K $2.5M $4.7M
 
Basic EPS (Cont. Ops) $0.29 $0.33 -$0.17 $0.76 $1.43
Diluted EPS (Cont. Ops) $0.28 $0.33 -$0.17 $0.75 $1.40
Weighted Average Basic Share $3.7M $3.6M $3.5M $3.3M $3.3M
Weighted Average Diluted Share $3.8M $3.7M $3.5M $3.3M $3.3M
 
EBITDA $1.5M $1.1M $2.1M $3.3M $3.4M
EBIT $1.3M $950K $1.8M $3M $3.1M
 
Revenue (Reported) $10M $11.1M $11.9M $14.9M $18.5M
Operating Income (Reported) $1.3M $950K $1.8M $3M $3.1M
Operating Income (Adjusted) $1.3M $950K $1.8M $3M $3.1M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Cash and Equivalents $5M $1.6M $4.1M $6.8M $7.2M
Short Term Investments $1.3M $755K $1.1M $4.2M --
Accounts Receivable, Net $10.9M $15.4M $10M $13.9M $16.4M
Inventory $8.4M $12.7M $16.2M $15.3M $22.2M
Prepaid Expenses -- $790K $296K $345K $410K
Other Current Assets -- -- -- -- --
Total Current Assets $24.8M $30.5M $30.5M $36.3M $47.3M
 
Property Plant And Equipment $12.9M $13.4M $13.2M $12.7M $12.3M
Long-Term Investments $1.7M $4.1M $7.5M $1.6M $148K
Goodwill -- -- -- -- --
Other Intangibles $186K $118K $81K $54K --
Other Long-Term Assets $67K $42K $42K $42K --
Total Assets $41.7M $51.2M $54.8M $54.2M $63.2M
 
Accounts Payable $2.3M $3.8M $2.3M $4.5M $4.6M
Accrued Expenses $1.9M $2.4M $2.7M $2.9M --
Current Portion Of Long-Term Debt $1.2M $3.3M $3.8M $4.4M --
Current Portion Of Capital Lease Obligations $344K $379K $416K $455K --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $6.3M $11.4M $9.7M $12.9M $14.6M
 
Long-Term Debt $14M $12.3M $10.5M $8.7M $9.9M
Capital Leases -- -- -- -- --
Total Liabilities $21.6M $25.8M $23.2M $23.3M $26.6M
 
Common Stock $8M $7.7M $6.8M $3.9M $704K
Other Common Equity Adj -- -- -- -- --
Common Equity $20.1M $25.4M $31.6M $30.9M $36.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $20.1M $25.4M $31.6M $30.9M $36.6M
 
Total Liabilities and Equity $41.7M $51.2M $54.8M $54.2M $63.2M
Cash and Short Terms $5M $1.6M $4.1M $6.8M $7.2M
Total Debt $15.2M $15.6M $14.4M $13.1M $16.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $6.7M $3.6M $2.9M $7.8M $10.6M
Short Term Investments $1.5M $813K $1M $4.7M --
Accounts Receivable, Net $10.1M $11M $11M $13.5M $18.2M
Inventory $8.9M $15.7M $16.3M $16.6M $21.6M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -$2K $201K $412K --
Total Current Assets $25.8M $31.2M $30.8M $38.3M $50.7M
 
Property Plant And Equipment $13.5M $13.3M $13M $12.7M $11.9M
Long-Term Investments $1.7M $1.9M $5.1M $1.5M $149K
Goodwill -- -- -- -- --
Other Intangibles $195K $108K $75K $47K --
Other Long-Term Assets $67K $42K $42K $44K --
Total Assets $41.9M $48M $49.6M $54.3M $64.3M
 
Accounts Payable $2.5M $3.5M $2.7M $4.4M $4M
Accrued Expenses $2.2M $3.2M $2.7M $4M --
Current Portion Of Long-Term Debt $1.2M $3.3M $2.8M $2.4M --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $6.2M $11.7M $8.3M $11.3M $13.6M
 
Long-Term Debt $13.6M $11.9M $10.1M $12.1M $9.2M
Capital Leases -- -- -- -- --
Total Liabilities $20.5M $23.5M $18.4M $23.4M $22.8M
 
Common Stock $8.2M $7.4M $7M $1.5M $905K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $21.4M $24.4M $31.2M $30.9M $41.5M
 
Total Liabilities and Equity $41.9M $48M $49.6M $54.3M $64.3M
Cash and Short Terms $6.7M $3.6M $2.9M $7.8M $10.6M
Total Debt $14.8M $15.2M $12.9M $14.5M $13.8M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $5.8M $4.6M $7.1M $2.1M $9M
Depreciation & Amoritzation $712K $726K $857K $1.2M $1.2M
Stock-Based Compensation $901K $1.3M $766K $605K $555K
Change in Accounts Receivable -$5.8M -$4.4M $5.4M -$3.9M -$2.5M
Change in Inventories -$199K -$4.2M -$3.5M $898K -$6.9M
Cash From Operations -$2.1M -$847K $5.5M $6.2M -$1.7M
 
Capital Expenditures $8.3M $1.7M $974K $983K $1.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.7M -$1.2M -$885K -$2.2M -$238K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $9.1M $2M $5.3M $4M --
Long-Term Debt Repaid -$351K -$1.2M -$6.1M -$4.8M --
Repurchase of Common Stock $5.5M $1.6M $1.5M $3.5M $3.5M
Other Financing Activities -$259K -- -$223K -- --
Cash From Financing $3.1M -$790K -$2.5M -$4.3M -$292K
 
Beginning Cash (CF) $3.7M $849K $2.9M $2.6M $419K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.7M -$2.9M $2.1M -$305K -$2.2M
Ending Cash (CF) $1M -$2M $5M $2.3M -$1.8M
 
Levered Free Cash Flow -$10.4M -$2.5M $4.5M $5.2M -$2.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.1M $1.2M -$615K $2.5M $4.7M
Depreciation & Amoritzation $190K $195K $280K $302K $311K
Stock-Based Compensation $300K $207K $189K $113K $161K
Change in Accounts Receivable $834K $4.3M -$1.1M $428K -$1.8M
Change in Inventories -$470K -$3M -$97K -$1.3M $649K
Cash From Operations $2.7M $2.9M $392K $1.9M $2.3M
 
Capital Expenditures $860K $178K $126K $431K $98K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$874K -$90K -$126K -$431K -$98K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1M -- $5M --
Long-Term Debt Repaid -$306K -$1.3M -$1.3M -$3.4M --
Repurchase of Common Stock $95K $354K -- $2.3M --
Other Financing Activities -- -$223K -- -$273K --
Cash From Financing -$371K -$853K -$1.3M -$1M -$2.1M
 
Beginning Cash (CF) $5.2M $2.8M $1.9M $3.1M $514K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5M $1.9M -$1M $450K $95K
Ending Cash (CF) $6.6M $4.7M $872K $3.5M $609K
 
Levered Free Cash Flow $1.8M $2.7M $266K $1.5M $2.2M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $5.7M $4.7M $5.3M $5.2M $11.2M
Depreciation & Amoritzation $743K $731K $942K $1.2M $1.2M
Stock-Based Compensation $1.2M $1.2M $748K $529K $603K
Change in Accounts Receivable -$4M -$946K $13K -$2.4M -$4.8M
Change in Inventories -$594K -$6.8M -$600K -$340K -$5M
Cash From Operations $1.5M -$656K $3M $7.7M -$1.3M
 
Capital Expenditures $9.1M $989K $922K $1.3M $913K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$4.6M -$451K -$921K -$2.5M $95K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $9.1M $3M $4.3M $9M --
Long-Term Debt Repaid -$496K -$2.3M -$6.1M -$6.9M --
Repurchase of Common Stock $5.6M $1.9M $1.2M $5.8M $1.2M
Other Financing Activities -- -- -- -- --
Cash From Financing $3.1M -$1.3M -$2.9M -$4M -$1.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$25K -$2.4M -$894K $1.2M -$2.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$7.6M -$1.6M $2M $6.4M -$2.2M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.1M $1.2M -$615K $2.5M $4.7M
Depreciation & Amoritzation $190K $195K $280K $302K $311K
Stock-Based Compensation $300K $207K $189K $113K $161K
Change in Accounts Receivable $834K $4.3M -$1.1M $428K -$1.8M
Change in Inventories -$470K -$3M -$97K -$1.3M $649K
Cash From Operations $2.7M $2.9M $392K $1.9M $2.3M
 
Capital Expenditures $860K $178K $126K $431K $98K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$874K -$90K -$126K -$431K -$98K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1M -- $5M --
Long-Term Debt Repaid -$306K -$1.3M -$1.3M -$3.4M --
Repurchase of Common Stock $95K $354K -- $2.3M --
Other Financing Activities -- -$223K -- -$273K --
Cash From Financing -$371K -$853K -$1.3M -$1M -$2.1M
 
Beginning Cash (CF) $5.2M $2.8M $1.9M $3.1M $514K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5M $1.9M -$1M $450K $95K
Ending Cash (CF) $6.6M $4.7M $872K $3.5M $609K
 
Levered Free Cash Flow $1.8M $2.7M $266K $1.5M $2.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock